Bharat Immunologicals (India) Management Performance

Analysis of Bharat Immunologicals manpower and management performance can provide insight into Bharat Immunologicals stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Bharat Immunologicals future performance. Check also Trending Equities.

Bharat Immunologicals Management Effectiveness

The company has return on total asset (ROA) of (1.69) % which means that it has lost $1.69 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (11.52) % meaning that it generated substantial loss on money invested by shareholders.

Bharat Immunologicals Profit Margins

The company has Profit Margin (PM) of (4.18) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (5.13) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.05.

Bharat Immunologicals Stakeholders

Sreeshan Raghavan Managing Director, Executive Director, Chairman of Share Transfer and Shareholders'/Investors' Grievance Committee and Member of Audit Committee
U Singh CFO
C Benjwal VP of FandA and Member of Share Transfer and Shareholders'/Investors' Grievance Committee
Mrs Bhatia Managing Director
M Bhatia Managing Director and Executive Director
Sunil Sharma Deputy General Manager of PandS
Sandip Lal Company Secretary and Member of Share Transfer and Shareholders'/Investors' Grievance Committee
Indrajit Singh Assistant General Manager of Utility

Leadership

Bharat Immunologicals Top Executives
Sreeshan Raghavan  Chairman
Managing Director, Executive Director, Chairman of Share Transfer and Shareholders'/Investors' Grievance Committee and Member of Audit Committee

Tenure Analysis

Bharat Immunologicals Employment Tenure
Bharat Immunologicals employes about 5 people. The company is managed by 8 executives with total tenure of roughly 0 years, averanging almost 0.0 years of service per executive having 0.0 employee per reported executive.

Manpower Efficiency

Return on Bharat Immunologicals Manpower
Revenue Per Employee 256 M
Revenue Per Executive 160 M
Net Loss Per Employee 10.7 M
Net Loss Per Executive 6.7 M

Earnings Per Share

Bharat Immunologicals Earnings Per Share
According to company disclosure Bharat Immunologicals Biologicals Corp Ltd has Earnings Per Share of -1.24 times. This is much lower than that of the sector, and significantly lower than that of Earnings Per Share industry, The Earnings Per Share for all stocks is over 1000% higher than the company.
Earnings per Share is one of the most important measures of the current share price of a firm, and is used by investors to determine the company overall profitability; especially when it is compared to the EPS of similar companies.